意大利长期护理机构居民多重用药与药物相互作用:处方日项目发现
该研究分析意大利82家长期护理机构2024年处方日数据,纳入3174名居民(平均年龄84.8岁,74.1%女性),平均处方7.7种药物。42.2%居民暴露于至少一种潜在临床相关药物相互作用(DDI),主要涉及中枢作用药物、累积抗胆碱能负担、血清素能组合及钾相关相互作用。更高的DDI负担与更大的药理复杂性、抑郁、睡眠障碍、心肺疾病及痴呆行为心理症状相关,而年龄更大、严重认知障碍、营养不良和吞咽困难与更少DDI相关。
要点
- 长期护理机构居民多重用药普遍,平均处方7.7种药物,42.2%暴露于潜在临床相关DDI。
- 常见DDI涉及中枢作用药物、累积抗胆碱能负担、血清素能组合及钾相关相互作用。
- 更高DDI负担与药理复杂性、抑郁、睡眠障碍、心肺疾病及痴呆行为心理症状相关。
核心结论
- 潜在临床相关DDI在意大利长期护理机构中常见,主要与居民层面临床复杂性相关,提示药物审查和处方精简是改善用药安全的目标。
研究设计与样本
- 意大利长期护理机构2024年处方日项目,是一项在82家长期护理机构开展的国家多中心点患病率研究。
- 采用解剖治疗化学系统分类处方,使用国际共识列表识别DDI,居民层面变量采用经过验证的工具评估,DDI负担关联采用单变量混合效应泊松回归模型分析。
- 分析纳入3174名居民,平均年龄84.8岁,74.1%为女性,平均处方7.7种药物。
主要发现
- 最常处方的药物为作用于神经系统、消化道和代谢及心血管系统的药物;最常用的活性物质为呋塞米、对乙酰氨基酚、泮托拉唑、喹硫平和聚乙二醇。
- 42.2%的居民暴露于至少一种潜在临床相关DDI,最常见涉及中枢作用药物、累积抗胆碱能负担、血清素能组合和钾相关相互作用。
- 更高的DDI负担与更大的药理复杂性、抑郁、睡眠障碍、心肺疾病及痴呆行为心理症状相关。
- 年龄更大、严重认知障碍、营养不良和吞咽困难与更少的DDI相关。
- 机构层面和人员配置特征显示有限差异,辅助生活机构在高DDI负担中代表性不足。
临床怎么用
- 对长期护理机构居民应常规进行药物审查,重点关注中枢作用药物、抗胆碱能负担、血清素能组合及钾相关相互作用。
- 对具有药理复杂性、抑郁、睡眠障碍、心肺疾病及痴呆行为心理症状的居民,应优先评估DDI风险并考虑处方精简。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medication prescribing in long-term care facilities (LTCFs) is characterized by widespread polypharmacy and frequent exposure to potentially clinically relevant drug-drug interactions (DDIs). METHODS: Data from the Italian Prescription Day in LTCFs 2024, a national multicenter point-prevalence study conducted in 82 LTCFs, were analyzed. Prescriptions were classified using the Anatomical Therapeutic Chemical system, and DDIs were identified using an international consensus list. Resident-level variables were assessed using validated tools, and associations with DDI burden were examined using univariate mixed-effects Poisson regression models. Facility-level organizational characteristics were described by center-level DDI burden. RESULTS: The analysis included 3174 residents (mean age 84.8 years; 74.1% women), with a mean of 7.7 prescribed drugs. Drugs acting on the nervous system, alimentary tract and metabolism, and cardiovascular system were most frequently prescribed; furosemide, paracetamol, pantoprazole, quetiapine, and macrogol were the most commonly used active substances. Overall, 42.2% of residents were exposed to at least one potentially clinically relevant DDI, most commonly involving centrally acting drugs, cumulative anticholinergic burden, serotonergic combinations, and potassium-related interactions. Higher DDI burden was associated with greater pharmacological complexity, depression, sleep disorders, cardiopulmonary disease, and behavioral and psychological symptoms of dementia, whereas older age, severe cognitive impairment, malnutrition, and dysphagia were associated with fewer DDIs. Facility-level and staffing characteristics showed limited differentiation, with assisted living facilities under-represented at higher DDI burden. CONCLUSIONS: Potentially clinically relevant DDIs are common in Italian LTCFs and are primarily associated with resident-level clinical complexity, highlighting targets for medication review and deprescribing to improve medication safety.
引用
- Malara A, Zucchelli A, Trevisan C, et al. Polypharmacy and drug-drug interactions in long-term care facilities residents: findings from the Italian Prescription Day Project. J Gerontol A Biol Sci Med Sci. 2026. PMID: 42001215. doi:10.1093/gerona/glag104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。